# White Label Biotechnology Dashboard - Tool: White Label Solutions - Last updated: July 2026 ## TL;DR No white-label biotechnology dashboard exists for resellers — and biotech is one of the highest-stakes verticals to be honest about. Regulated lab data belongs in validated LIMS or ELN software (FDA 21 CFR Part 11, GxP), not a generic white-label portal. A custom build at $13K–$25K is scoped strictly to the non-regulated ops layer: R&D pipeline, samples, budget, and investor reporting. ## Frequently asked questions ### How much does a white-label biotechnology dashboard cost? No dedicated white-label biotech dashboard product exists for resellers. For a non-regulated ops reporting layer using a horizontal portal, expect $0–$5,000 setup and $14–$497/month. Validated LIMS and ELN software for regulated lab data is enterprise-priced separately — sales-gated, typically much higher. A custom ops dashboard runs $13,000–$25,000 one-time plus ~$100/month hosting. The dominant cost in biotech is always the validated lab-software layer, not the ops dashboard on top of it. ### How fast can I launch a branded biotechnology ops dashboard? A horizontal portal configured as an R&D reporting shell takes 1–3 weeks. The real constraint is often the integration work to pull data from your validated LIMS/ELN systems into the dashboard — that connection layer typically adds 1–2 weeks of development work regardless of platform. A full custom build runs 6–10 weeks. The compliance-scope definition (which data is regulated, which is ops) should happen before any platform configuration starts. ### Can a white-label dashboard replace a LIMS or ELN for FDA-regulated data? No. This is the most important answer on this page. FDA 21 CFR Part 11 compliance for electronic records requires specifically validated software with documented IQ/OQ/PQ, audit trails, and e-signature controls. A generic dashboard — white-label or custom — cannot substitute for a validated LIMS or ELN. Regulated experimental data belongs in validated systems. A dashboard is appropriate only for the non-regulated ops layer: pipeline, budget, resource allocation, and investor reporting. ### Do I own my data with a biotechnology dashboard? With a horizontal portal, you possess your data while the contract is active but the database stays with the vendor — you typically get dashboard-level exports, not a portable ops database. A custom build gives you full ownership of all ops-layer data. Note that your regulated lab data ownership is governed separately by your LIMS/ELN vendor contracts — those terms should always be reviewed carefully given the compliance implications of biotech data migration. ### What does '21 CFR Part 11' mean for my dashboard decision? 21 CFR Part 11 is the FDA regulation governing electronic records and electronic signatures in regulated industries. Systems that store experiment records, batch records, or other regulated data for FDA-regulated programs must comply — meaning the software must be validated, maintain audit trails, and support compliant e-signatures. A business ops dashboard (pipeline status, budget, investor reports) does not typically trigger Part 11 requirements. Your LIMS, ELN, and any system storing assay results or manufacturing batch data does. Scope your dashboard to non-regulated data and you are outside Part 11 requirements. ### White-label portal vs custom build — what is the real cost difference? Over 3 years, a horizontal portal at $497/month totals ~$17,900 in platform fees — but it cannot execute biotech pipeline logic or integrate with LIMS/ELN systems without additional custom development. A custom build at $13,000–$25,000 one-time plus ~$3,600 hosting totals $16,600–$28,600 with full integration, pipeline logic, and data ownership. The cost difference is modest; the capability difference in biotech is significant — custom delivers the multi-system integration and bespoke pipeline definitions that a generic portal cannot. ### Can RapidDev build a custom biotechnology ops dashboard? Yes. RapidDev builds custom R&D operations dashboards for biotech clients in 6–10 weeks at $13K–$25K fixed price, scoped to the non-regulated ops layer: pipeline stage-gate tracking, budget and burn-rate dashboards, grant milestone management, equipment scheduling, investor reporting templates, and integration with validated LIMS/ELN systems via API or export. Regulated lab data always stays in validated systems — that is a firm scope boundary. We offer a free scoping call to map your data architecture and compliance scope before any build commitment. ### What regulatory compliance does a biotech dashboard need to address? An ops dashboard covering non-regulated data (pipeline, budget, investor reporting) does not itself require 21 CFR Part 11 validation. However: all data you display must come from validated sources via secure integration; access controls must prevent unauthorized viewing of sensitive R&D data; activity logging should track who accessed or exported what and when. If any clinical patient data is ever surfaced in the dashboard, HIPAA applies immediately. Confirm with your regulatory and legal teams which data categories are in scope for your specific programs before finalizing dashboard architecture. --- Source: https://www.rapidevelopers.com/white-label/biotechnology-dashboard © RapidDev — https://www.rapidevelopers.com/white-label/biotechnology-dashboard